| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5899049 | Diabetes Research and Clinical Practice | 2016 | 16 Pages |
Abstract
Whether adoption of HbA1c as a screening test for GDM would benefit pregnant women remains to be determined. However, HbA1c might be a useful tool to predict patients at increased risk of several adverse pregnancy outcomes.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Min Ye, Yuanyuan Liu, Xiaopei Cao, Fengjuan Yao, Bin Liu, Yanbing Li, Zilian Wang, Haipeng Xiao,